Ownership history in MACQUARIE GROUP LTD · 15 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 761,740 | -143,545 | -15.9% | 0.02% | $15.0M | $19.70 |
| 2025 Q2 | REDUCED | 905,285 | -29,640 | -3.2% | 0.02% | $19.6M | $21.70 |
| 2025 Q1 | ADDED | 934,925 | +252,273 | +37.0% | 0.03% | $22.7M | $24.25 |
| 2024 Q4 | ADDED | 682,652 | +495,752 | +265.2% | 0.02% | $14.2M | $20.87 |
| 2022 Q3 | REDUCED | 186,900 | -2,011 | -1.1% | 0.00% | $2.4M | $12.83 |
| 2022 Q2 | UNCHANGED | 188,911 | — | 0% | 0.00% | $1.3M | $7.01 |
| 2022 Q1 | REDUCED | 188,911 | -600 | -0.3% | 0.00% | $1.6M | $8.29 |
| 2021 Q4 | REDUCED | 189,511 | -23,495 | -11.0% | 0.00% | $1.3M | $6.77 |
| 2021 Q3 | ADDED | 213,006 | +2,200 | +1.0% | 0.00% | $1.1M | $5.30 |
| 2021 Q2 | ADDED | 210,806 | +85,216 | +67.9% | 0.00% | $1.2M | $5.75 |
As of 2025 Q4 — sorted by position size